This study investigates the role of endogenous platelet-activating factor (PAF) in the production of nitric oxide (NO) by constitutive and inducible isoforms of NO synthase (NOS) in endotoxin shock. In anesthetized rats, 3 hours of endotoxemia resulted in a fall in mean arterial blood pressure (MAP) from 127±5 (control) to 61±7 mm Hg and a reduction of the pressor responses to norepinephrine (NE, 1 jug* kg-') from 33±3 (control) to 17±2 mm Hg. Endotoxemia for 3 hours also resulted in a significant reduction in the contractile effects of NE (10-8 to 10-6 mol/L) in thoracic aortas ex vivo. This hyporeactivity to NE was due to an enhanced formation of NO, for it was restored by the NOS inhibitor macrophages and vascular smooth muscle cells, resulting in the formation of large quantities of NO.'14"5 Production of NO in response to LPS is the principal mediator of hypotension, peripheral vasodilatation, and vascular hyporeactivity to vasoconstrictor agents in endotoxemia. '6-22 The aims of the present study were to investigate whether (1) the beneficial hemodynamic effects of the PAF receptor antagonist WEB 2086 in endotoxemia involve inhibition of NO synthesis by constitutive and/or inducible isoform of NOS and (2) PAF stimulates the formation of NO by activation and/or induction of NOS in vivo.
P latelet-activating factor (PAF) is a lipid mediator with a wide variety of pharmacologic actions.1-3 Intravenous administration of PAF mimics several cardiovascular features of circulatory shock, including hypotension, peripheral vasodilatation, plasma extravasation, and cardiac failure.4,5 Elevated plasma levels of PAF are found in endotoxemia,6-8 and specific receptor antagonists of PAF, including WEB 2086, exert protective effects in animal models of endotoxin shock.9"10 PAF and certain cytokines stimulate the release of each other via positive feedback cycles. For instance, PAF is released in response to lipopolysaccharide (LPS), interleukin-1, or tumor necrosis factor (TNF) and, in turn, mediates and/or enhances the release and actions of these cytokines."1-13 LPS, interleukin-1, and TNF also induce a calcium-independent nitric oxide (NO) synthase (NOS) in a variety of cells including macrophages and vascular smooth muscle cells, resulting in the formation of large quantities of NO. '14"5 Production of NO in response to LPS is the principal mediator of hypotension, peripheral vasodilatation, and vascular hyporeactivity to vasoconstrictor agents in endotoxemia. '6-22 The aims of the present study were to investigate whether (1) the beneficial hemodynamic effects of the PAF receptor antagonist WEB 2086 in endotoxemia involve inhibition of NO synthesis by constitutive and/or inducible isoform of NOS and (2) PAF stimulates the formation of NO by activation and/or induction of NOS in vivo.
Materials and Methods

Hemodynamic Measurements
Male Wistar rats (260 to 320 g, Glaxo Laboratories Ltd, Greenford, Middlesex, UK) were anesthetized with thiopentone sodium (Trapanal, 3% solution, 120 mg* kg-l IP). The trachea was cannulated to facilitate respiration, and rectal temperature was maintained at (model P23XL, Spectramed, Stratham, NH) for the measurement of phasic and mean arterial blood pressure (MAP) and heart rate (HR), which were displayed on a polygraph recorder (model 7D, Grass Instruments, Quincy, Mass). Left and right femoral veins were cannulated for the administration of drugs.
Experimental Procedure
On completion of the surgical procedure, cardiovascular parameters were allowed to stabilize for 20 minutes. After recording baseline hemodynamic parameters, animals were treated with vehicle (n=8) or WEB 2086 (5 mg* kg`IV, n=9), and 10 minutes later the pressor response to norepinephrine (NE, 1 ug * kg`IV) was recorded. At 20 minutes after injection of vehicle or WEB 2086, animals received Escherichia coli LPS (10 mg* kg-1 IV, in 0.3 mL saline) as a slow injection over 2 minutes, and pressor responses to NE (1 ,ugg kg-') were reassessed at 60, 120, and 180 minutes after LPS injection. In a separate group of rats, WEB 2086 (5 mg* kg`IV) was administered 90 minutes after LPS injection (10 mg * kg`1 IV, n=3).
To investigate the effect of PAF on the cardiovascular parameters studied, rats were treated with PAF (2 Ugg* kg-1 IV), and pressor responses to NE (1 ugg kg-') were recorded at 60, 120, and 180 minutes after PAF (n= 6). This protocol was also used in separate groups of animals pretreated with either (1) dexamethasone (3 mg* kg-1 IV, 60 minutes before PAF, n=3), (2) WEB 2086 (5 mg* kg-1 IV, 20 minutes before PAF, n=3), or (3) the NOS inhibitor NG-methyl-L-arginine (L-NMA, 300 g.g* kg`* min-1 infusion starting 10 were assessed before and 20 minutes after treatment with the NOS inhibitor N0-nitro-L-arginine methyl ester (L-NAME, 3 x 10`mol/L).
NOS Assay
Lungs from animals treated with LPS (with or without WEB 2086 pretreatment) or PAF (with or without dexamethasone or WEB 2086 pretreatment) were removed at 180 minutes and frozen in liquid nitrogen. Lungs from sham-operated rats were also isolated for quantification of baseline NOS activity. Lungs were stored for no more than 2 weeks at -80°C before assay. Frozen lungs were homogenized on ice using an UltraTurrax T 25 homogenizer (Janke & Kunkel, IKA Labortechnik, Staufen i. Br., Germany) in a buffer composed of (mmol/L) Tris The direct effect of WEB 2086 (10`1U to 10`mol/L) on NOS-mediated L-citrulline formation was investigated in lung homogenates from LPS-treated rats in the presence of all the above-mentioned cofactors after a 20-minute incubation.
Protein concentration was measured spectrophotometrically in 96-well plates by the method of Bradford,25 using bovine serum albumin as standard.
Endotoxin Measurements
To elucidate whether endotoxin contamination or release contributes to the induction of NOS by intravenous injection of PAF, endotoxin levels in PAF solutions and in plasma samples obtained at 60 and 120 minutes after PAF injection were measured by the Limulus amebocyte lysate assay, as modified by Harris et al. 26 Briefly, blood samples (1 mL ) were collected from the femoral artery into sterile tubes and immediately centrifuged at 10 000g for 5 minutes to obtain platelet-rich plasma. Platelet-rich plasma was diluted 1:10 under sterile conditions with endotoxin-free water and heated to 75°C for 5 minutes to inactivate an endotoxin inhibitor present in plasma. Samples were stored at -80°C for up to 21 
Materials
Calmodulin, bacterial lipopolysaccharide (E. coli serotype 0127:B8), hexamethonium bromide, MTT, NADPH, L-NAME, NE, PAF (1-hexadecyl/octadecyl-2-acetyl-sn-glycero-3 phosphocholine), Dowex 50W anion exchange resin, and the Limulus amebocyte lysate assay were obtained from Sigma Chemical Co, Poole, Dorset, UK. L-NMA monoacetate was obtained from Noadrenaline (-log M) was also followed by a significant increase in HR (Fig  lb) . LPS treatment significantly attenuated the pressor responses to NE (1 ,g . kg-1) at 60, 120, and 180 minutes after its administration (P<.01, n=8, Fig lc) . WEB 2086 itself had no effect on any of the hemodynamic parameters studied (Fig 1) . LPS-treated rats that had been pretreated with WEB 2086 maintained significantly higher MAP values when compared with rats treated with LPS alone (Fig la) . However, WEB 2086 pretreatment did not affect the development of the tachycardia that was elicited by LPS (Fig lb) . WEB 2086 did not affect the hyporeactivity to NE at 60 and 120 minutes after LPS injection. At 180 minutes after LPS, however, the pressor responses to NE in animals treated with WEB 2086 returned to a value similar to the pre-LPS values, whereas they remained reduced in the LPS-treated control animals (Fig lc) .
Administration of WEB 2086 (5 mg. kg`1 IV) at 90 minutes after LPS injection had no effect on the subsequent changes in MAP, HR, or pressor responses to NE (n=3, data not shown).
WEB 2086 Protects Against the Development of Vascular Hyporeactivity After LPS Injection Ex Vivo
In rat aortic rings obtained from sham-operated rats (control), NE (10 8 to 10-6 mol/L) caused a dosedependent increase in vascular tone (Fig 2) . The contractions caused by NE were significantly reduced in Fig 2a) . Treatment of vessels with L-NAME in vitro (3 x 10-4 mol/L) did not enhance the contractions to NE in control rings. However, L-NAME significantly enhanced the contractile responses to NE in aortic rings obtained from LPS-treated rats that were pretreated with either vehicle or WEB 2086 to a level not different from the control level (Fig 2b) .
Aortic rings from LPS-treated rats also showed a blunted contractile response to 25 mmol/L potassium (P<.01, Fig 2c) . WEB 2086 pretreatment of rats significantly protected against the development of this vascular hyporeactivity to potassium (P<.05, Fig 2c) . Although in vitro treatment of control aortic rings with L-NAME (3 x 10`4 mol/L) did not enhance the contractile responses to potassium, L-NAME significantly enhanced (P<.05) the contractile responses produced by potassium in aortic rings obtained from LPS-treated animals. In contrast to the contractions to NE, the contractions to potassium after LPS and in vitro L-NAME remained significantly reduced when compared with control contractions (P<.05, Fig 2c) .
WEB 2086 Inhibits the Induction of NOS by LPS In Vivo
A small calcium-independent NOS activity was detectable in lung homogenates obtained from shamoperated control animals. However, after 3 hours of endotoxemia, there was a substantial induction of NOS activity in lung homogenates (Fig 3) . This induced NOS activity was significantly reduced (by 31 + 10%, P< .05) in animals pretreated with WEB 2086 at 20 minutes before LPS administration (Fig 3) . In contrast, administration of WEB 2086 (5 mg * kg`1 IV) at 90 minutes after LPS injection did not affect the degree of NOS induction in lung homogenates at 180 minutes after LPS injection (n=3, data not shown).
To elucidate whether WEB 2086 directly inhibits the induced NOS activity in lung homogenates in vitro, we measured the NOS activity after incubation with increasing concentrations of the PAF antagonist. WEB (Fig 4) (Fig 4) . Thus, L-NMA significantly shortened the duration of the hypotension caused by PAF. To further investigate the involvement of NO in the acute hypotension elicited by PAF, the effect of L-NMA on the hypotension caused by PAF (0.2 gg* kg`1 and 1 ,gg kg-1) was studied. L-NMA did not reduce the absolute maximum of the hypotension elicited by either doses of PAF (Figs 5 and 6 ), but it abbreviated the duration of the hypotension (Figs 5 and 6 ).
Intravenous injection of PAF into anesthetized rats caused within 180 minutes an induction of calciumindependent NOS activity (Fig 7a) , which was prevented by pretreatment with dexamethasone (3 mg* kg-1 IV, 60 minutes before PAF, n=3) or WEB 2086 (5 mg* kg-lIV, 20 minutes before PAF, n=3). As shown in Fig 7a, PAF (2 gg kg`1 IV) caused an increase in NOS activity, which was greater than that seen with 0.1 mg* kg`LPS but less than that seen with 2 mg . kg LPS. Consistent with this relative activity of inducible NOS, the fall in MAP at 180 minutes after PAF (2 ,gg kg-') was intermediate between that elicited by 0.1 mg kg`1 and 2 mg. kg`1 LPS. There was a highly significant correlation between the fall in MAP at 180 minutes and the induced NOS activity in sham-operated control rats and rats treated with LPS (0.1 or 2 mg kg-') or PAF (with or without dexamethasone or WEB 2086 pretreatment) (r2=.972, P<.01, Fig 7b) .
To elucidate whether a severe and sustained hypotension alone is sufficient to induce NOS, animals were given hexamethonium to lower blood pressure to approximately 50 mm Hg for 180 minutes (Figs 4 and 7) . Although the hypotension elicited by hexamethonium was more pronounced than that produced by PAF ( Figs  4 and 7) , hexamethonium treatment was not associated with an induction of a calcium-independent NOS activity (Fig 7) .
Contamination by LPS of the PAF solutions used in this study was less than 0.5 pg/mL. Plasma levels of LPS were undetectable at 60 and 120 minutes after administration of PAF (n=3).
WEB 2086 Inhibits Nitrite Production by Cultured Murine Macrophages
The concentration of nitrite measured in the culture medium of J774.2 macrophages stimulated with LPS (1 ,g * mL-1) for 24 hours was 23 ±0.8 gmol/L. This amount of nitrite production is similar to that previously shown to be elicited by LPS in J774.2 or RAW264 macrophages.30,31 Pretreatment for 30 minutes with WEB 2086 (10-13 to 10`8 mol/L) concentration-dependently reduced the production of nitrite by LPS-stimulated J774.2 macrophages (Fig 8a) without affecting cell respiration (data not shown). Maximal inhibition (35±5%) was observed at 10`mol/L (n=9). In contrast, when given 2 hours after LPS, WEB 2086 did not inhibit nitrite production (Fig 8b) . PAF alone (10`10 to 10`66 mol/L) neither induced nitrite production nor enhanced that elicited by LPS (1 ,gg mL-1) in a 24-hour interval (n=6, data not shown). Discussion The present study demonstrates that endogenous PAF contributes to the induction of NOS by LPS, because (1) TNF and interleukin-1 each stimulate PAF release from monocytes, macrophages, and endothelial cells in vitro.1"-'3 Interestingly, PAF antagonists inhibit the release of TNF in response to LPS in cultured macrophages37 and in the anesthetized rat.38 Moreover, small amounts of PAF substantially potentiate both hypotension and organ damage caused by LPS in the anesthetized rat.39 Thus, we speculate that the release of PAF by LPS contributes to the induction of NOS by enhancing the release and/or action of cytokines.240 As WEB 2086 inhibits both extracellular and intracellular receptors of PAF,41 the present study does not distinguish whether extracellular release of PAF6-8 or intracellular generation of PAF3 41 is more important for the induction of NOS.
In addition to attenuating NOS induction and the consequent delayed fall in MAP in rats treated with LPS, WEB 2086 prevented the immediate fall in MAP. The immediate and delayed hypotension and vascular hyporeactivity to vasoconstrictor agents elicited by LPS in the rat are due to an enhanced formation of NO that is triggered by two distinct mechanisms, namely, activation of constitutive NOS (early phase) and induction of NOS (delayed phase). 17,22.42 The present data demonstrate that the PAF-induced acute hypotension is in part mediated by NO, for its duration was significantly reduced by L-NMA, an inhibitor of NO synthesis.
However, L-NMA did not reduce the maximum fall in MAP caused by PAF. Similarly, L-NMA reduces the duration of the hypotensive response caused by acetylcholine in the anesthetized guinea pig without affecting the magnitude of the fall in MAP produced by this endothelium-dependent vasodilator.43 PAF is known to cause endothelium-dependent relaxation of isolated rat blood vessels (thoracic aortic rings and perfused mesenteric artery) by stimulating the production of NO from the constitutive NOS in endothelial cells. 44, 45 Moreover, PAF releases NO from polymorphonuclear granulocytes46 by activating the constitutive NOS. Thus, the release of PAF in response to LPS triggers the release of NO from the constitutive NOS, which in turn contributes to the hypotension in the early phase of endotoxemia.
In conclusion, this study demonstrates that endogenous PAF is a mediator of the induction of NOS by LPS in cultured macrophages and in the anesthetized rat. Moreover, the acute fall in MAP produced by PAF in the anesthetized rat is, in part, due to activation of the constitutive NOS. Thus, some of the beneficial hemodynamic effects of PAF receptor antagonists documented in various animal models of endotoxemia may be due to a reduced synthesis of NO. Elizabeth Wood for the expert assistance with cell cultures and to Ms Julie Piper for technical assistance.
